IDO inhibitors have gained significant attention in the field of cancer immunotherapy. By inhibiting IDO, it is possible to prevent the local depletion of tryptophan and the accumulation of kynurenine, which can suppress T-cell activity. This inhibition can potentially enhance the body's immune response against tumors. Additionally, IDO inhibition is being explored for its potential in treating various autoimmune disorders and chronic infections.
